Eucerin arrived in India in October 2024, on Nykaa, selling the proposition the whole pharmacy shelf runs on: dermatological skin care, clinically proven, recommended by dermatologists. Within thirteen months the Indian advertising council had upheld two complaints about how that was being said here.
It is also true that the molecule behind Eucerin’s biggest Indian range has a published randomised trial behind it. Both are on the record, and this page holds them together.
Eucerin’s Indian range runs ₹36 to ₹126 per millilitre, and the 50 ml Anti-Pigment Night Cream costs about 35% less here than its German list price. The active behind that range, Thiamidol, has an evaluator-blinded randomised trial published in a mainstream dermatology journal. The advertising around it carries two upheld findings from the Advertising Standards Council of India — one of which went partly in Eucerin’s favour. Prices checked 4 September 2026.
Snapshot
- Origin
- Germany. Eucerit patented by Dr Isaac Lifschütz — filed 1900, granted 1902; Beiersdorf bought it in 1911
- Ultimate owner
- Beiersdorf AG, Hamburg; the Herz family holds 53.50% through maxingvest
- Sold in India by
- Nivea India Private Limited, CIN U24240MH2005FTC153536, incorporated 26 May 2005
- In India since
- October 2024, launched on Nykaa
- Made where
- The Anti-Pigment Night Cream sold here declares Poland
- Price band in India
- ₹900 to ₹3,780 MRP, checked 4 September 2026
How it started
The invention is genuinely old. Isaac Lifschütz filed the Eucerit patent in 1900 and was granted it in 1902 — an ointment base that would hold water stably in oil. In 1911 he sold it to Beiersdorf and joined the company as a chemist, which is when Hamburg could start building pharmacy ointments on it.
- 1900Lifschütz files the Eucerit patent; granted 1902
- 1911Beiersdorf buys the patent and hires the inventor
- 1950Eucerin pH5, “the acid ointment”, launches
- 1990sFace care for sensitive and damaged skin
- 2019Thiamidol enters the range
- Oct 2024Eucerin launches in India, on Nykaa
The compound is 125 years old. The consumer brand a reader buys is much younger, and in India it is younger still.
That matters because of how the heritage is sold. Beiersdorf’s brand page says “for over 125 years, Eucerin has developed effective, highly tolerable, and clinically proven solutions”; eucerin.in rounds the same history to “over 100 years”. The thing patented in 1900 was an ointment base. Take the dated events rather than either round number.
There is a family connection most Indian buyers will not know. Eucerit is the emulsifier that made NIVEA Creme possible in 1911. One descendant of that invention became the cheapest blue tin in the country; the other became a pharmacy brand selling at ₹57.60 a millilitre.
What they actually make
The Indian range on Nykaa’s Eucerin page ran to 30 products on 4 September 2026, built on three pillars: Anti-Pigment, which carries Thiamidol; DermoPurifyer for acne-prone skin; and a sun range of four SPF products.
Where it is made is not where the marketing implies. The declaration block on the Indian listing for the Anti-Pigment Night Cream, read on 4 September 2026, gives Country of Origin as Poland, the manufacturer as Beiersdorf Manufacturing Poznań with Colep Polska at Kleszczów, and both the packer and the importer as NIVEA India Pvt Ltd, Mumbai. That is one product, so this page says the Anti-Pigment Night Cream sold here declares Poland and nothing wider. Poland sits inside the EU cosmetics regime and Beiersdorf’s own plant is named first, so this is an accuracy point rather than a quality one.
It also settles who sells Eucerin here. There is no Eucerin India or Beiersdorf India on either record read: the importer on the pack and the advertiser named by the advertising council are the same company, Nivea India Private Limited. Marketer and maker are different parties, the same distinction that separates Bata India, the listed company running the shops, from the brand on the box. Very few consumer brands here own the plant that fills their product — Campus is one that does — and Eucerin is not among them.
Now the ingredient, because it is the strongest thing on this page. Thiamidol is isobutylamido thiazolyl resorcinol, and Beiersdorf’s own pages say little about it: “a patented ingredient”, with no patent number and no study attached. The literature says considerably more. In 2021 the Journal of the European Academy of Dermatology and Venereology published an evaluator-blinded randomised controlled trial by an independent Brazilian academic group — 50 women with facial melasma, 90 days, Thiamidol twice daily against 4% hydroquinone at bedtime. The Thiamidol arm’s melasma score fell 43% against the hydroquinone arm’s 33%, with no statistically significant difference between them. The authors’ conclusion: the improvement on Thiamidol “did not differ from that of 4% hydroquinone cream”. A 2024 systematic review in the Journal of Drugs in Dermatology gathers the clinical work on the molecule, and a 2024 paper in JEADV Clinical Practice covers phototypes IV to VI — the range that matters most for an Indian reader.
Two limits belong in the same breath. It is one trial of 50 women, not a literature, and allergic contact dermatitis appeared in 8% of the Thiamidol arm — both in the trial’s own results. None of this is medical advice, and this page recommends the product for nothing.
The published trial used a stated dose of Thiamidol. No Eucerin page we read gives the concentration in the jar sold here, so the box will not tell you whether you are buying the dose that was trialled. Weigh the evidence as evidence for the molecule, not for the product.
On formulation, the German ingredient list for the same 50 ml night cream puts Thiamidol fourteenth of twenty-four ingredients, and ingredient order is not a dose. We did not get the Indian list for that jar, so we draw no comparison between the two formulas. Two things on the German list are worth a line on a brand that calls itself medical skin care: the product contains Parfum, and Alcohol Denat. is the fourth ingredient. Neither is hidden — both are printed on the box.
What Eucerin costs in India
Start with the surprise. The same 50 ml Anti-Pigment Night Cream carries an Indian MRP of ₹2,880 against a German list price of €39.75 — ₹4,397 at ₹110.62 to the euro, the Federal Reserve’s H.10 rate for 28 August 2026. India is cheaper than the brand’s home market, which cuts against the reflex that imported skincare always costs more here.
- Germany, list price (UVP)
- €39.75 — about ₹4,397
- India, MRP
- ₹2,880
- Gap
- 35% cheaper in India
- Checked on
- 4 September 2026
Street prices narrow it without closing it: ₹2,736 on Nykaa and ₹2,448 on Amazon in India on 4 September 2026, against €33.69 at a German pharmacy site the same day. One product on one date is not a rule for the range. Eucerin is imported by NIVEA India — its owner’s own Indian company — rather than by a third-party distributor, and that is the structural difference worth watching on an imported pharmacy brand.
Cheaper than Germany is not the same as cheap. On pack sizes that could be read, the ladder looks like this.
| Product | MRP | Per ml |
|---|---|---|
| Anti-Pigment Dual Serum, 30 ml | ₹3,780 | ₹126.00 |
| Anti-Pigment Night Cream, 50 ml | ₹2,880 | ₹57.60 |
| DermoPurifyer Oil Control 3x Serum, 40 ml | ₹1,440 | ₹36.00 |
Nykaa product pages, checked 4 September 2026. Nykaa’s brand page does not print net quantity for the other listings, so those stay headline prices.
Other headline MRPs on the same date: Face Illuminating Serum ₹2,700, Anti-Pigment Day Cream SPF30 ₹2,880, Pigment Control Sunscreen Fluid SPF50+ ₹1,800, Anti-Pigment Cleansing Gel 2% AHA ₹1,100, Hydro Protect Ultra-Light Sunscreen SPF50+ ₹990. Retailer discounts on the day ran 5% to 15%, so the printed MRP is a ceiling rather than the going rate — the same gap that runs through mass-market footwear brands like Sparx. Divide by millilitres before you decide anything.
Who Eucerin is actually for
The buyer with a pigmentation concern who wants an over-the-counter active with published human trial data behind it, and who has read what that data covers. That is a narrow description, and it is the honest one. Eucerin is one of very few brands on the Indian shelf where the headline molecule can be traced to a paper rather than to a badge.
It is not for a buyer choosing on price per millilitre. At ₹126 a millilitre the Dual Serum is roughly six times what The Ordinary charges for its niacinamide serum and about twenty times what CeraVe’s moisturising cream costs per gram in India. It is also not for a buyer who wants sun protection backed by a published report: Eucerin sells four SPF products here and, on the pages read on 4 September 2026, publishes no test method, laboratory, report or PA rating for any of them.
A test happening is not a test passing, and a panel agreeing is not an instrument measuring.
Reputation and controversies
Eucerin’s central active has better published evidence behind it than almost anything else on this shelf, which is precisely why the advertising record repays reading closely.
On 16 October 2025 the Advertising Standards Council of India upheld a complaint against Nivea India Private Limited over advertising for the Eucerin DermoPurifyer range, carried in an Instagram post. The claims examined were “Dermatologist Approved – Safe & Effective for Acne-Prone Skin”, “Visibly Clear Skin in 2 Weeks” and “This dermat-trusted range helps to control sebum, reduce inflammation, and prevent future breakouts”. The council recorded that those claims contravened Chapter I of its code, the chapter dealing with truthful and honest representation. Read that one precisely: it is a finding about the claims, not about a missing advertising label, and no influencer-disclosure guideline was cited in it.
A second matter was decided on 9 June 2025, over an Instagram advertisement for Eucerin Anti-Pigment Night Care, and it did not go one way.
| Claim examined | Outcome, 9 June 2025 |
|---|---|
| “Radiant skin overnight with patented Thiamidol” | Contravened Chapter I — upheld |
| “Overnight skin regeneration**” | Contravened Chapter I — upheld |
| “Long-term even skin***” | Not in contravention — cleared |
Two of the three claims were upheld and the third, the long-term one, was examined and cleared. Reporting only the first two of those rows would be reporting half a decision.
Both findings need their limits stated, and they are real limits. The council is an industry body that regulates its own members; it is not a statutory regulator and it imposes no penalty. Each decision was about one advertisement as it stood on Instagram at the time — not about the product, not about the pack, and not a standing prohibition on any form of words for anyone. Nobody has ruled on Eucerin’s Indian website as it reads today, and this page does not suggest otherwise.
What that website says is worth setting down. On 4 September 2026 the Indian page for the same night cream described a product that “helps you achieve radiant skin overnight”, said it “works on overnight skin regeneration**”, and said it “delivers an even skin in the long run***”. The double and triple asterisks appear on the page; no footnote text defining them appears on it. The one substantiation note there describes a product-in-use study of 120 women over four weeks in 2023, by MWResearch GmbH, Germany. None of the four phrases from the October 2025 finding appears on the DermoPurifyer page read the same day.
Read the panel numbers for what they measure. “92% said the product regenerates skin overnight” and “99% agree product gives even skin” come from that 120-woman study; “96% confirm anti-blemish, anti-shine and anti-mark benefits” comes from a separate study of 100 volunteers over four weeks in 2022, also by MWResearch. The verbs are “said”, “agree” and “confirm”: volunteers reported what they thought. That is a different class of evidence from an instrument measuring a change.
Credit where it is earned, because one footnote here is better than the category norm. The Anti-Pigment range page carries “achieve 97% spot reduction, professionally graded by dermatologists”, footnoted to a product-in-use study of 120 women across 11 European countries over 12 weeks, Beiersdorf AG, 2019 to 2022 — and a study matching that description sits in the peer-reviewed literature. A brand claim on an Indian page that traces to a published paper is rare enough to say out loud. The limits are equally reportable: the panel was European, and “professionally graded by dermatologists” describes who scored the photographs, not who recommends the product to you.
At brand level the vocabulary is looser. On 4 September 2026 eucerin.in carried “Dermat Tested Skin Care Products for Healthy Skin”, “dermatologically proven skincare solutions” and, in the page’s meta description, “dermatologist-recommended Eucerin skin care products”. No study, panel or citation is attached to any of those on the homepage. Three different phrases, three different meanings, and most buyers will read them as one claim.
Two things run in the brand’s favour and belong here. No Indian court decision naming Eucerin appears in the public case record searched on 4 September 2026 — read that as nothing found rather than a clean bill, since not every consumer forum and state regulator is indexed there. And the advertising council’s file on Eucerin, read the same day, holds two matters and no finding at all about sun protection. Untested by a regulator is not the same as verified: the SPF number is published on four Indian products and nothing behind the number is.
Buying it in India
Eucerin sells here through Nykaa, Amazon and pharmacy retail rather than its own storefront, and the seller on a marketplace listing may be a reseller. The checks below are about reading the pack and the page rather than the front of the bottle.
Read the free-text declaration, not the origin box
The tidy “country of origin” field in a listing’s spec panel has been wrong on imported skincare. The block that counts names manufacturer, packer, importer and net quantity in full. Read that one, or read the box in the shop.
Ask the seller for the import registration number
Registration before import is mandatory under the Cosmetics Rules 2020, and the certificate is held by the Indian importer. The register is not open to public search, so the number is something you ask for. Some imported packs print it.
Follow the asterisk
Where a claim carries a marker, find the footnote it points to and read what was measured — panel size, duration, who ran it, and whether people were asked or skin was graded. If the marker resolves to nothing on the page, that is what it resolves to.
Want a report behind an SPF number
An SPF figure is worth what its test is worth: method, standard, laboratory, subjects and a PA rating for UVA. Several Indian brands publish all of that. Eucerin’s Indian sun pages, read on 4 September 2026, publish none of it.
Divide by millilitres before you pay
Pack sizes vary sharply here. ₹3,780 for 30 ml is ₹126 a millilitre; ₹1,440 for 40 ml is ₹36. Compute it at the till, and treat the MRP as a ceiling — discounts ran 5% to 15% on 4 September 2026.
On counterfeits this page reports nothing, because no enforcement outcome, seizure order or judgment about counterfeit Eucerin in India was found. Buy from a seller you can go back to, and keep the invoice.
Common questions
Is Eucerin made in Germany?
Not the jar checked here. The declaration on the Indian listing for the Anti-Pigment Night Cream, read on 4 September 2026, gives Poland as the country of origin, with Beiersdorf Manufacturing Poznań and Colep Polska at Kleszczów named as manufacturer. That is one product, so read the box in your hand for the rest.
Who sells Eucerin in India?
Nivea India Private Limited — Beiersdorf’s own Indian company, CIN U24240MH2005FTC153536, incorporated in May 2005. It is the declared importer on the pack and the advertiser named on both advertising council records. There is no separate Eucerin India company.
Does Thiamidol actually work?
There is published human trial data, which is more than most actives on this shelf can show. An evaluator-blinded randomised trial in JEADV in 2021 followed 50 women with facial melasma for 90 days and found no statistically significant difference between Thiamidol and 4% hydroquinone. It is one trial of 50 people, 8% of the Thiamidol arm developed allergic contact dermatitis, and the concentration in the product sold here is not published. Reporting, not medical advice.
What did the advertising council decide about Eucerin?
Two matters, both upheld, both about product claims. On 16 October 2025 it upheld a complaint over DermoPurifyer advertising using “Dermatologist Approved” and “dermat-trusted” wording, under Chapter I of its code. On 9 June 2025 it examined three Anti-Pigment claims, upheld two and cleared the third. It is a self-regulatory industry body, each ruling concerned one advertisement as it then stood, and no ruling has been made on the brand’s website as it reads today.
How we research and verify brand audits: our methodology.
References
- ASCI Complaint Outcomes, read 4 September 2026 — the 16 October 2025 DermoPurifyer finding and the 9 June 2025 Anti-Pigment split decision, with the claims quoted
- Beiersdorf, Eucerin brand history — the 1900 patent, the 1911 sale, pH5 in 1950, the 1990s face care
- Beiersdorf, Eucerin brand page — the “over 125 years” and “clinically proven” brand claims
- Beiersdorf, shareholder structure — maxingvest at 53.50%, free float 37.13%
- Beiersdorf, full-year results 2025, 2 March 2026 — group sales €9.9 billion; no Eucerin-only figure is published
- Amazon India, Eucerin Anti-Pigment Night Cream 50 ml, 4 September 2026 — the declaration block: Poland, Poznań and Colep Polska, NIVEA India as packer and importer
- Zauba Corp, Nivea India Private Limited — CIN, incorporation date, registered office
- Eucerin international, Thiamidol ingredient page — the “patented ingredient” claim with no patent number or study attached
- Lima PB et al., JEADV, 2021 — the evaluator-blinded randomised trial, 50 women, 90 days, Thiamidol against 4% hydroquinone, 8% allergic contact dermatitis
- Klein PA et al., Journal of Drugs in Dermatology, November 2024 — systematic review of the clinical studies on the molecule
- Schuster C et al., JEADV Clinical Practice, 2024 — Thiamidol in phototypes IV to VI
- eucerin.in, Anti-Pigment Night Cream, 4 September 2026 — the overnight and long-run claims, the asterisk markers, the 120-woman study footnote
- eucerin.in, Anti-Pigment range, 4 September 2026 — the 97% spot-reduction claim and its 11-country, 12-week footnote
- eucerin.in, DermoPure Clinical, 4 September 2026 — the 96% figure and its 100-volunteer footnote; the four upheld phrases do not appear on the page
- eucerin.in homepage, 4 September 2026 — the brand-level “dermat tested” and “dermatologically proven” wording
- Nykaa Luxe, Eucerin brand page, 4 September 2026 — the 30-product Indian range and every Indian MRP and selling price used above
- Shop Apotheke, Eucerin Anti-Pigment Nachtpflege 50 ml, 4 September 2026 — the €39.75 German list price, the €33.69 selling price and the German ingredient list
- Federal Reserve H.10, released 31 August 2026 — the euro rate used, ₹110.62, for 28 August 2026
- Global Cosmetics News, 23 October 2024 — the Indian launch on Nykaa
- CDSCO, guidance on registration and import of cosmetics, 19 January 2021 — registration before import, and what the imported pack must carry
Eucerin does the one thing this shelf almost never does: its headline active leads to a published, independently run randomised trial rather than to a badge. Its Indian pages carry footnotes with a panel size, a duration and a named research house, and one of those traces to a paper. And on the single product compared here it costs about 35% less than its German list price, because its owner imports it through its own Indian company rather than a distributor taking a cut.
The scepticism goes to what is not printed. The trial has a dose; the jar does not name one. Four sun products carry an SPF number and no method, laboratory, report or PA rating. The panel figures say what 120 or 100 volunteers reported, not what an instrument measured. And the phrase the whole category sells on — dermatologist approved, dermat-trusted — is the phrase the advertising council upheld a complaint about on 16 October 2025, on a specific advertisement, under a code its own members write.
At ₹57.60 a millilitre for the night cream and ₹126 for the serum, a buyer is entitled to the dose and to the sun-protection report — and on the pages read on 4 September 2026, neither is published.
